Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Diclofenac Sodium and Misoprostol Delayed-Release Tablets, USP These highlights do not include all the information needed to use DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE TABLETS . DICLOFENAC SODIUM AND MISOPROSTOL delayed-release tablets, for oral use Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
Diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications. For a list of factors that may increase the risk of NSAID-induced gastric and duodenal ulcers and their complications [see Warnings and Precautions (5.2) ].
- generic_name
- diclofenac sodium and misoprostol
- product_names
- Diclofenac Sodium and Misoprostol
- ndc
- 42291-232, 0591-0397, 42291-232-90, 42291-232-60, 42291-233, 0591-0398, 42291-233-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en